Get started
Author

Frank K Bedu-Addo

Observed names: F.K. Bedu-Addo, Frank Bedu-Addo, Frank Bedu‐Addo, Frank K. Bedu-Addo
ORCID: 0000-0003-2305-1997
Observed ORCID: 0000-0003-2305-1997
OpenAlex ID: A5081812286
Effects of Polyethyleneglycol Chain Length and Phospholipid Acyl Chain Composition on the Interaction of Polyethyleneglycol-phospholipid Conjugates with Phospholipid: Implications in Liposomal Drug Delivery
1996 · Frank K. Bedu-Addo, P. Tang, et al. · Pharmaceutical Research · 105
Interaction of PEG-phospholipid conjugates with phospholipid: implications in liposomal drug delivery
1995 · Frank K. Bedu-Addo, Leaf Huang · Advanced Drug Delivery Reviews · 72
Antigen Priming with Enantiospecific Cationic Lipid Nanoparticles Induces Potent Antitumor CTL Responses through Novel Induction of a Type I IFN Response
2019 · Siva K Gandhapudi, Martin Ward, et al. · The Journal of Immunology · 59
Preformulation development of recombinant pegylated staphylokinase SY161 using statistical design
2002 · Frank Bedu-Addo, Randall Moreadith, et al. · AAPS PharmSci · 28
PDF
Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies.
2021 · Julius Strauss, Charalampos S. Floudas, et al. · Journal of Clinical Oncology · 20
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts
2016 · Sonja Althammer, Keith Steele, et al. · Journal for ImmunoTherapy of Cancer · 18
PDF
Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice
2023 · Siva K. Gandhapudi, Hua Shi, et al. · Viruses · 14
PDF
Effect of Matrix Lipid Chain Length on Liposomes Containing Cholesterol and Ganglioside GM1: Implications in Drug Delivery
1996 · F.K. Bedu-Addo, L. Huang · Journal of Pharmaceutical Sciences · 13
Use of Biophysical Characterization in Preformulation Development of a Heavy-Chain Fragment of Botulinum Serotype B: Evaluation of Suitable Purification Process Conditions
2004 · Frank K. Bedu-Addo, Catharine Johnson, et al. · Pharmaceutical Research · 10
La Promotion of Co Fischer-Tropsch Catalysts
1994 · S. Vada, A.M. Kazi, et al. · Studies in surface science and catalysis · 9
Preliminary Safety of PDS0101 (Versamune +HPVmix) and Pembrolizumab Combination Therapy in Subjects with Recurrent/Metastatic Human Papillomavirus-16 Positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)
2022 · L. Wood, A.V. Chintakuntlawar, et al. · International Journal of Radiation Oncology*Biology*Physics · 7
R-DOTAP (Versamune): A novel enantiospecific cationic lipid nanoparticle that induces CD4 and CD8 cellular immune responses to whole protein and tumor-specific peptide antigens.
2020 · Lauren Virginia Wood, Siva K Gandhapudi, et al. · Journal of Clinical Oncology · 6
Monitoring manufacturing process yields, purity and stability of structural variants of PEGylated staphylokinase mutant SY161 by quantitative reverse‐phase chromatography
2003 · Catharine Johnson, Mabel Royal, et al. · Biomedical Chromatography · 6
PDS0101, a novel type I interferon and CD8 T-cell activating immunotherapy, in combination with pembrolizumab in subjects with recurrent/metastatic HPV16-positive head and neck squamous cell carcinoma (HNSCC).
2022 · Jared Weiss, Ashish V. Chintakuntlawar, et al. · Journal of Clinical Oncology · 5
Understanding Lyophilization Formulation
2004 · Frank Bedu‐Addo · 1
Preformulation Development of Protein Drugs
2007 · Frank K. Bedu-Addo · CRC Press eBooks
Works count: 16
Citation count: 373
H-index: 9
I10-index: 9
Year
Topic
Type